Cyanotic nephropathy and use of non-ionic contrast agents during cardiac catherization in patients with cyanotic congenital heart disease

Cardiology in the Young

Volumn 10, Issue 1, 2000, Pages 8-14

  Dittrich, Sven ^a,b   Kurschat, Katrin ^a   Dähnert, Ingo ^a   Vogel, Michael ^a   Müller, Christian ^a   Lange, Peter E ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Blood viscosity; Cardiac catheterization; Contrast induced nephrotoxicity; Cyanotic congenital heart disease; Renal failure

Indexed keywords

CONTRAST MEDIUM;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD; BLOOD VISCOSITY; CHILD; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOSIS; DRUG EFFECT; FEMALE; HEART CATHETERIZATION; HUMAN; KIDNEY; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RADIOGRAPHY; RISK FACTOR; URINE;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; BLOOD VISCOSITY; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; CYANOSIS; FEMALE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0033628782     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1047951100006314     Document Type: Article

References (25)

1. Spear G. The glomerulus in cyanotic congenital heart disease and primary pulmonary hypertension. Nephron 1964;1:238-248.
2. Dittrich S, Haas NA, Bührer C, Müller C, Dähnert I, Lange PE. Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr 1998;87:949-954.
3. Krull F, Ehrich JH, Wurster U, Toel U, Rothganger S, Luhmer I. Renal involvement in patients with congenital cyanotic heart disease. Acta Paediatr Scand 1991;80:1214-1219.
4. Akita H, Matsuoka S, Kuroda Y. Nephropathy in patients with cyanotic congenital heart disease. Tokushima J Exp Med 1993;40:47-53.
5. Tommaso CL. Contrast-induced nephrotoxicity in patients undergoing cardiac catheterization. Cathet Cardiovasc Diagn 1994;31:316-321.
6. Carraro M, Malalan F, Antonione R, Stacul F, Cova M, Petz S, Assante M, Grynne B, Haider T, Palma LD, Faccini L. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial. Eur Radiol 1998;8:144-147.
7. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-178.
8. Spinler SA, Goldfarb S. Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media. Ann Pharmacother 1992;26:56-64.
9. Stacul F, Cova M, Assante M, Hougens Grynne B, Haider T. Comparison between the efficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency. Br J Radiol 1998;71:918-922.
10. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254-261.
11. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, Bashore TM. Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med 1989;320:149-153.
12. Almen T. The etiology of contrast medium reactions. Invest Radiol 1994;29 Suppl 1:S37-45.
13. Solomon R. Radiocontrast-induced nephropathy. Semin Nephrol 1998;18:551-557.
14. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 1992;41:1408-1415.
15. Simpson LO. A hypothesis proposing increased blood viscosity as a cause of proteinuria and increased vascular permeability. Nephron 1982;31:89-93.
16. Simpson LO. Blood viscosity induced proteinuria. Nephron 1984;36:280-281.
17. Laranja SM, Ajzen H, Schor N. Nephrotoxicity of low-osmolality contrast media. Ren Fail 1997;19:307-314.
18. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast mediaassociated nephrotoxicity. Semin Nephrol 1997;17:15-26.
19. Parfrey PS, Barrett BJ. High-osmolality and low-osmolality contrast agents. N Engl J Med 1992;327:204-205.
20. Nunez BD, Allon M. Effect of cardiac catheterization on renal function. Clin Nephrol 1990;34:263-266.
21. Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA, Timmis GC, OòÀNeill WW. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999;33:403-411.
22. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420.
23. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989;86:649-652.
24. Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Haramiti N. Radiocontrast-associated renal dysfunction: a comparison of lower- osmolality and conventional high-osmolality contrast media. AJR Am J Roentgenol 1991;157:59-65.
25. Leonardi M. Contrast medium dose and renal failure. Radiology 1998;207:832-833.